Advertisement

Index by author

July 01, 1983; Volume 24,Issue 1

A

  1. Abell, C W

    1. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
      R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell
      Molecular Pharmacology July 1983, 24 (1) 60-68;

  2. Alberts, P

    1. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
      O Nordström, P Alberts, A Westlind, A Undén and T Bartfai
      Molecular Pharmacology July 1983, 24 (1) 1-5;

  3. Anderson, D C

    1. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 48-54;
    2. Inhibition of [3H]acetylcholine active transport by tetraphenylborate and other anions.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 55-59;

B

  1. Bartfai, T

    1. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
      O Nordström, P Alberts, A Westlind, A Undén and T Bartfai
      Molecular Pharmacology July 1983, 24 (1) 1-5;

  2. Beerman, T

    1. The effects of the antitumor protein auromomycin on HeLa S3 nuclei. Release of soluble chromatin.
      F Rauscher, G Mueller and T Beerman
      Molecular Pharmacology July 1983, 24 (1) 97-102;

  3. Bouchard, J

    1. Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.
      J Bouchard and R L Momparler
      Molecular Pharmacology July 1983, 24 (1) 109-114;

  4. Brown, J H

    1. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
      J Dunlap and J H Brown
      Molecular Pharmacology July 1983, 24 (1) 15-22;

  5. Bylund, D B

    1. Forskolin does not activate sperm adenylate cyclase.
      L R Forte, D B Bylund and W L Zahler
      Molecular Pharmacology July 1983, 24 (1) 42-47;

C

  1. Cantoni, O

    1. Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
      R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 77-83;
    2. Correlations of DNA strand breaks and their repair with cell survival following acute exposure to mercury(II) and X-rays.
      O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 84-89;

  2. Conney, A H

    1. Betamethasone-mediated activation of biphenyl 2-hydroxylation in rat liver microsomes. Studies on possible mechanisms.
      M S Miller, M T Huang, A M Jeffrey and A H Conney
      Molecular Pharmacology July 1983, 24 (1) 137-145;

  3. Costa, M

    1. Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
      R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 77-83;
    2. Correlations of DNA strand breaks and their repair with cell survival following acute exposure to mercury(II) and X-rays.
      O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 84-89;

  4. Croft, J E

    1. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
      I G Robertson, C Serabjit-Singh, J E Croft and R M Philpot
      Molecular Pharmacology July 1983, 24 (1) 156-162;

D

  1. Denney, R M

    1. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
      R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell
      Molecular Pharmacology July 1983, 24 (1) 60-68;

  2. Drewes, L R

    1. An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels.
      R J Zeleznikar, E E Quist and L R Drewes
      Molecular Pharmacology July 1983, 24 (1) 163-167;

  3. Dubé, C E

    1. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
      M Murray, C F Wilkinson, C Marcus and C E Dubé
      Molecular Pharmacology July 1983, 24 (1) 129-136;

  4. Duch, D S

    1. Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
      D S Duch, C L Lee, M P Edelstein and C A Nichol
      Molecular Pharmacology July 1983, 24 (1) 103-108;

  5. Dunlap, J

    1. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
      J Dunlap and J H Brown
      Molecular Pharmacology July 1983, 24 (1) 15-22;

E

  1. Edelstein, M P

    1. Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
      D S Duch, C L Lee, M P Edelstein and C A Nichol
      Molecular Pharmacology July 1983, 24 (1) 103-108;

  2. Evans, R M

    1. Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
      R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 77-83;

F

  1. Fairhurst, A S

    1. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
      S A Thayer and A S Fairhurst
      Molecular Pharmacology July 1983, 24 (1) 6-9;

  2. Fischer, P H

    1. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
      P H Fischer, D G Murphy and R Kawahara
      Molecular Pharmacology July 1983, 24 (1) 90-96;

  3. Forte, L R

    1. Forskolin does not activate sperm adenylate cyclase.
      L R Forte, D B Bylund and W L Zahler
      Molecular Pharmacology July 1983, 24 (1) 42-47;

  4. Fraser, C M

    1. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
      L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter
      Molecular Pharmacology July 1983, 24 (1) 10-14;

  5. Fritz, R R

    1. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
      R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell
      Molecular Pharmacology July 1983, 24 (1) 60-68;

H

  1. Huang, M T

    1. Betamethasone-mediated activation of biphenyl 2-hydroxylation in rat liver microsomes. Studies on possible mechanisms.
      M S Miller, M T Huang, A M Jeffrey and A H Conney
      Molecular Pharmacology July 1983, 24 (1) 137-145;

I

  1. Ishii, K

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

J

  1. Jeffrey, A M

    1. Betamethasone-mediated activation of biphenyl 2-hydroxylation in rat liver microsomes. Studies on possible mechanisms.
      M S Miller, M T Huang, A M Jeffrey and A H Conney
      Molecular Pharmacology July 1983, 24 (1) 137-145;

  2. Jerina, D M

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  3. Jung, C Y

    1. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
      L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter
      Molecular Pharmacology July 1983, 24 (1) 10-14;

K

  1. Kamataki, T

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

  2. Kato, R

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

  3. Kawahara, R

    1. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
      P H Fischer, D G Murphy and R Kawahara
      Molecular Pharmacology July 1983, 24 (1) 90-96;

  4. King, S C

    1. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 48-54;
    2. Inhibition of [3H]acetylcholine active transport by tetraphenylborate and other anions.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 55-59;

  5. Kouakou, Y

    1. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
      J C Meunier, Y Kouakou, A Puget and C Moisand
      Molecular Pharmacology July 1983, 24 (1) 23-29;

L

  1. Lee, C L

    1. Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
      D S Duch, C L Lee, M P Edelstein and C A Nichol
      Molecular Pharmacology July 1983, 24 (1) 103-108;

  2. Levin, W

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  3. Lilly, L

    1. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
      L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter
      Molecular Pharmacology July 1983, 24 (1) 10-14;

  4. Lucier, G W

    1. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
      C Thompson and G W Lucier
      Molecular Pharmacology July 1983, 24 (1) 69-76;

M

  1. Maeda, K

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

  2. Makar, A B

    1. Effect of nitrous oxide and methionine treatments on hepatic S-adenosylmethionine and methylation reactions in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology July 1983, 24 (1) 124-128;

  3. Marcus, C

    1. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
      M Murray, C F Wilkinson, C Marcus and C E Dubé
      Molecular Pharmacology July 1983, 24 (1) 129-136;

  4. Matsuda, N

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

  5. Meunier, J C

    1. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
      J C Meunier, Y Kouakou, A Puget and C Moisand
      Molecular Pharmacology July 1983, 24 (1) 23-29;

  6. Miller, M S

    1. Betamethasone-mediated activation of biphenyl 2-hydroxylation in rat liver microsomes. Studies on possible mechanisms.
      M S Miller, M T Huang, A M Jeffrey and A H Conney
      Molecular Pharmacology July 1983, 24 (1) 137-145;

  7. Moisand, C

    1. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
      J C Meunier, Y Kouakou, A Puget and C Moisand
      Molecular Pharmacology July 1983, 24 (1) 23-29;

  8. Momparler, R L

    1. Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.
      J Bouchard and R L Momparler
      Molecular Pharmacology July 1983, 24 (1) 109-114;

  9. Mueller, G

    1. The effects of the antitumor protein auromomycin on HeLa S3 nuclei. Release of soluble chromatin.
      F Rauscher, G Mueller and T Beerman
      Molecular Pharmacology July 1983, 24 (1) 97-102;

  10. Murphy, D G

    1. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
      P H Fischer, D G Murphy and R Kawahara
      Molecular Pharmacology July 1983, 24 (1) 90-96;

  11. Murray, M

    1. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
      M Murray, C F Wilkinson, C Marcus and C E Dubé
      Molecular Pharmacology July 1983, 24 (1) 129-136;

N

  1. Nichol, C A

    1. Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
      D S Duch, C L Lee, M P Edelstein and C A Nichol
      Molecular Pharmacology July 1983, 24 (1) 103-108;

  2. Nordström, O

    1. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
      O Nordström, P Alberts, A Westlind, A Undén and T Bartfai
      Molecular Pharmacology July 1983, 24 (1) 1-5;

P

  1. Palatini, P

    1. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
      P Palatini
      Molecular Pharmacology July 1983, 24 (1) 30-41;

  2. Parsons, S M

    1. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 48-54;
    2. Inhibition of [3H]acetylcholine active transport by tetraphenylborate and other anions.
      D C Anderson, S C King and S M Parsons
      Molecular Pharmacology July 1983, 24 (1) 55-59;

  3. Patel, N T

    1. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
      R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell
      Molecular Pharmacology July 1983, 24 (1) 60-68;

  4. Patierno, S R

    1. Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
      R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 77-83;

  5. Philpot, R M

    1. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
      I G Robertson, C Serabjit-Singh, J E Croft and R M Philpot
      Molecular Pharmacology July 1983, 24 (1) 156-162;

  6. Puget, A

    1. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
      J C Meunier, Y Kouakou, A Puget and C Moisand
      Molecular Pharmacology July 1983, 24 (1) 23-29;

Q

  1. Quist, E E

    1. An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels.
      R J Zeleznikar, E E Quist and L R Drewes
      Molecular Pharmacology July 1983, 24 (1) 163-167;

R

  1. Rauscher, F

    1. The effects of the antitumor protein auromomycin on HeLa S3 nuclei. Release of soluble chromatin.
      F Rauscher, G Mueller and T Beerman
      Molecular Pharmacology July 1983, 24 (1) 97-102;

  2. Robertson, I G

    1. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
      I G Robertson, C Serabjit-Singh, J E Croft and R M Philpot
      Molecular Pharmacology July 1983, 24 (1) 156-162;

S

  1. Sayer, J M

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  2. Seeman, P

    1. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
      L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter
      Molecular Pharmacology July 1983, 24 (1) 10-14;

  3. Serabjit-Singh, C

    1. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
      I G Robertson, C Serabjit-Singh, J E Croft and R M Philpot
      Molecular Pharmacology July 1983, 24 (1) 156-162;

T

  1. Tephly, T R

    1. Effect of nitrous oxide and methionine treatments on hepatic S-adenosylmethionine and methylation reactions in the rat.
      A B Makar and T R Tephly
      Molecular Pharmacology July 1983, 24 (1) 124-128;

  2. Thakker, D R

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  3. Thayer, S A

    1. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
      S A Thayer and A S Fairhurst
      Molecular Pharmacology July 1983, 24 (1) 6-9;

  4. Thompson, C

    1. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
      C Thompson and G W Lucier
      Molecular Pharmacology July 1983, 24 (1) 69-76;

U

  1. Undén, A

    1. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
      O Nordström, P Alberts, A Westlind, A Undén and T Bartfai
      Molecular Pharmacology July 1983, 24 (1) 1-5;

V

  1. van Bladeren, P J

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  2. Venter, J C

    1. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
      L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter
      Molecular Pharmacology July 1983, 24 (1) 10-14;

  3. Vyas, K P

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

W

  1. Wang, D S

    1. Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
      R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa
      Molecular Pharmacology July 1983, 24 (1) 77-83;

  2. Westlind, A

    1. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
      O Nordström, P Alberts, A Westlind, A Undén and T Bartfai
      Molecular Pharmacology July 1983, 24 (1) 1-5;

  3. Widen, S G

    1. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
      R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell
      Molecular Pharmacology July 1983, 24 (1) 60-68;

  4. Wilkinson, C F

    1. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
      M Murray, C F Wilkinson, C Marcus and C E Dubé
      Molecular Pharmacology July 1983, 24 (1) 129-136;

Y

  1. Yagi, H

    1. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
      K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina
      Molecular Pharmacology July 1983, 24 (1) 115-123;

  2. Yamazoe, Y

    1. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
      T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato
      Molecular Pharmacology July 1983, 24 (1) 146-155;

Z

  1. Zahler, W L

    1. Forskolin does not activate sperm adenylate cyclase.
      L R Forte, D B Bylund and W L Zahler
      Molecular Pharmacology July 1983, 24 (1) 42-47;

  2. Zeleznikar, R J

    1. An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels.
      R J Zeleznikar, E E Quist and L R Drewes
      Molecular Pharmacology July 1983, 24 (1) 163-167;
Back to top

In this issue

Advertisement